Diet
Diet
08/29/2022
A new study investigated the relationship between 2 healthy eating patterns and the prodromal features of Parkinson disease. Lead author Samantha A. Molsberry, PhD, answered our questions about her team’s...
08/29/2022
Diet
Diet
08/29/2022
A new study investigated the relationship between 2 healthy eating patterns and the prodromal features of Parkinson disease. Lead author Samantha A. Molsberry, PhD, answered our questions about her team’s...
08/29/2022
Diet
Diet
08/29/2022
A new study investigated the relationship between 2 healthy eating patterns and the prodromal features of Parkinson disease. Lead author Samantha A. Molsberry, PhD, answered our questions about her team’s...
08/29/2022
Treatment
Treatment
08/29/2022
In a new study, researchers sought to clarify how the gut microbe may influence chronic gastrointestinal disease. The coauthors Michael C. Hoaglin, MD, and Melissa Agnello, PhD, answered our questions about...
08/29/2022
Treatment
Treatment
08/29/2022
In a new study, researchers sought to clarify how the gut microbe may influence chronic gastrointestinal disease. The coauthors Michael C. Hoaglin, MD, and Melissa Agnello, PhD, answered our questions about...
08/29/2022
Health Care Disparities
Health Care Disparities
08/27/2022
How does sex and race impact the care patients with migraine receive? Robert Cowan, MD, answered our questions about his research examining this relationship, a topic he presented at AAN 2021.
08/27/2022
Health Care Disparities
Health Care Disparities
08/27/2022
How does sex and race impact the care patients with migraine receive? Robert Cowan, MD, answered our questions about his research examining this relationship, a topic he presented at AAN 2021.
08/27/2022
Expert Q&A
Expert Q&A
08/20/2022
Despite being approved for use by the FDA in 2019, many questions remain on the safety, tolerability, and efficacy of ubrogepant in certain patient populations with migraine in the real-world population....
08/20/2022
Expert Q&A
Expert Q&A
08/20/2022
Despite being approved for use by the FDA in 2019, many questions remain on the safety, tolerability, and efficacy of ubrogepant in certain patient populations with migraine in the real-world population....
08/20/2022
Expert Q&A
Expert Q&A
08/20/2022
Despite being approved for use by the FDA in 2019, many questions remain on the safety, tolerability, and efficacy of ubrogepant in certain patient populations with migraine in the real-world population....
08/20/2022